Web Stats Provided By Google Analytics

Saturday, January 25, 2014

FDA Rejects Expanded Labeling for Feraheme

The FDA has issued a complete response letter for the supplemental new drug application for Feraheme injection for intravenous use.

http://ift.tt/1g2x1Xc

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts